Served as CEO of Beijing Hanmi Marketing Group (HMG), of Mom Korea, and Koripo Port
DxVx announced on the 20th that it has appointed Vice President Geon-sang Yoo as the CEO of Korea Biopharmaceuticals, which it recently signed a takeover contract with.
Geon-sang Yoo, CEO of Korea Biopharmaceuticals Korea, started as CEO of Hanmi IT in Beijing in 2005.
DX&VX recently signed a contract to acquire a 100% stake in Korea Biopharmaceuticals, a health functional food manufacturing company, for 15 billion won, and explained that it has completed an integrated business structure ‘R&D-production-distribution’. Along with the existing bio-healthcare commissioned development and manufacturing (CDMO) business, the company plans to commercialize various developed items of the Microbiome Research Center under its own brand and expand it to the domestic and overseas markets as well as the Chinese market.
On the other hand, Korea Biopharmaceuticals Korea has 10 production lines for powders, tablets, and capsules in the first and second factories with a total area of about 4,000 pyeong. equipped Currently, it is producing about 120 products from 60 partner companies as OEM/ODM.
Source: 코메디닷컴 by kormedi.com.
*The article has been translated based on the content of 코메디닷컴 by kormedi.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!